KOCAA
Knights of Columbus Asset Advisors’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $538K | Sell |
38,479
-1,796
| -4% | -$25.1K | 0.03% | 277 |
|
|
2025
Q1 | $548K | Buy |
40,275
+1,058
| +3% | +$14.4K | 0.04% | 260 |
|
|
2024
Q4 | $799K | Buy |
39,217
+98
| +0.3% | +$2K | 0.05% | 248 |
|
|
2024
Q3 | $1.14M | Sell |
39,119
-18,876
| -33% | -$550K | 0.08% | 235 |
|
|
2024
Q2 | $1.35M | Buy |
57,995
+18,554
| +47% | +$431K | 0.09% | 241 |
|
|
2024
Q1 | $809K | Sell |
39,441
-37,911
| -49% | -$778K | 0.06% | 251 |
|
|
2023
Q4 | $1.66M | Buy |
77,352
+39,224
| +103% | +$842K | 0.11% | 238 |
|
|
2023
Q3 | $787K | Buy |
38,128
+1,151
| +3% | +$23.7K | 0.07% | 247 |
|
|
2023
Q2 | $1.09M | Buy |
+36,977
| New | +$1.09M | 0.1% | 241 |
|